Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
Neonc Technologies, Inc.
Neonc Technologies, Inc.
Novartis
Toray Industries, Inc
Shanghai Junshi Bioscience Co., Ltd.
GI Innovation, Inc.
Eli Lilly and Company
GlaxoSmithKline
Masonic Cancer Center, University of Minnesota
Pharmacyclics LLC.
Eastern Cooperative Oncology Group
Nektar Therapeutics
Calithera Biosciences, Inc
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)